Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
44
SDXAY Quote, Financials, Valuation and Earnings
Last price:
$16.20
Seasonality move
:
-0.13%
Day range:
$15.89 - $16.43
52-week range:
$15.89 - $25.00
Dividend yield:
3.52%
P/E ratio:
65.88x
P/S ratio:
0.46x
P/B ratio:
2.82x
Volume:
51K
Avg. volume:
58.3K
1-year change:
-23.87%
Market cap:
$11.8B
Revenue:
$25.7B
EPS (TTM):
$0.42
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Revenue | $21.5B | $20.8B | $22.3B | $24.1B | $25.7B | |
| Revenue Growth (YoY) | -13.5% | -3.24% | 7.04% | 7.88% | 6.97% | |
| Cost of Revenues | $18.8B | $17.9B | $19.6B | $21.2B | $22.7B | |
| Gross Profit | $2.8B | $2.9B | $2.7B | $2.9B | $3.1B | |
| Gross Profit Margin | 12.83% | 13.9% | 12.12% | 12.02% | 11.96% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.1B | $2.2B | $1.8B | $1.9B | $1.9B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2.2B | $2.2B | $1.9B | $1.9B | $2B | |
| Operating Income | $566M | $645.4M | $833M | $945.7M | $1.1B | |
| Net Interest Expenses | $318.6M | $123.1M | $97.9M | $99.9M | $67M | |
| EBT. Incl. Unusual Items | -$246.2M | $283.3M | $798.9M | $795.9M | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | $199.2M | $248.6M | -$616.3M | |
| Income Tax Expense | $109.2M | $120.7M | $226.7M | $192.3M | $269.2M | |
| Net Income to Company | $72.4M | $405.2M | $893.5M | $900M | $1.1B | |
| Minority Interest in Earnings | $4.5M | $2.4M | -$6.6M | -$8.5M | -$9.7M | |
| Net Income to Common Excl Extra Items | -$350.9M | $166.1M | $764.8M | $843.7M | $181.6M | |
| Basic EPS (Cont. Ops) | -$0.48 | $0.23 | $1.05 | $1.16 | $0.25 | |
| Diluted EPS (Cont. Ops) | -$0.48 | $0.22 | $1.03 | $1.14 | $0.24 | |
| Weighted Average Basic Share | $728.9M | $730M | $731.5M | $730.6M | $732.3M | |
| Weighted Average Diluted Share | $739.6M | $738.1M | $740.3M | $738.5M | $740.4M | |
| EBITDA | $919.1M | $1.1B | $1.4B | $1.5B | $1.8B | |
| EBIT | -$79.1M | $417.1M | $919.9M | $964.8M | $1.3B | |
| Revenue (Reported) | $21.5B | $20.8B | $22.3B | $24.1B | $25.7B | |
| Operating Income (Reported) | $566M | $645.4M | $833M | $945.7M | $1.1B | |
| Operating Income (Adjusted) | -$79.1M | $417.1M | $919.9M | $964.8M | $1.3B | |
| Period Ending | 2003-02-28 | 2004-02-28 | 2005-02-28 | 2006-02-28 | 2007-02-28 | |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | -- | $3.9B | $3.9B | $4.5B | |
| Revenue Growth (YoY) | 9.77% | -- | 8.72% | 0.51% | 13.89% | |
| Cost of Revenues | -- | -- | $3.3B | $3.4B | $3.8B | |
| Gross Profit | -- | -- | $550.3M | $560.2M | $658.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $372.8M | $372.5M | $428.7M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | $412.7M | $371.5M | $419.8M | |
| Operating Income | $3.2B | -- | $137.6M | $188.8M | $238.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | $101.7M | $159.6M | $206.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $37.9M | $61.2M | $73.3M | |
| Net Income to Company | -- | -- | $277.1M | $377.5M | -- | |
| Minority Interest in Earnings | -- | -- | -$3M | -$2M | -$4M | |
| Net Income to Common Excl Extra Items | $45.8M | -- | $61.8M | $95.4M | $129.7M | |
| Basic EPS (Cont. Ops) | $0.06 | -- | $0.08 | $0.12 | $0.17 | |
| Diluted EPS (Cont. Ops) | $0.06 | -- | $0.08 | $0.12 | $0.16 | |
| Weighted Average Basic Share | $806.2M | -- | $795.1M | $779.7M | $780.1M | |
| Weighted Average Diluted Share | $821.4M | -- | $795.1M | $786.1M | $791.8M | |
| EBITDA | $3.2B | -- | $137.6M | $188.8M | $238.6M | |
| EBIT | $3.2B | -- | $137.6M | $188.8M | $238.6M | |
| Revenue (Reported) | $3.2B | -- | $3.9B | $3.9B | $4.5B | |
| Operating Income (Reported) | $3.2B | -- | $137.6M | $188.8M | $238.6M | |
| Operating Income (Adjusted) | $3.2B | -- | $137.6M | $188.8M | $238.6M | |
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Revenue | $21.7B | $20.9B | $21.9B | $24.5B | $25.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $18.9B | $18B | $19.2B | $21.5B | $22.8B | |
| Gross Profit | $2.8B | $2.9B | $2.7B | $2.9B | $3.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.2B | $2.2B | $1.8B | $1.9B | $1.9B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2.2B | $2.3B | $1.8B | $2B | $2B | |
| Operating Income | $554.3M | $647.4M | $834.8M | $961.3M | $1.1B | |
| Net Interest Expenses | $326.3M | $123.5M | $97.2M | $101.8M | $67.5M | |
| EBT. Incl. Unusual Items | -$280.6M | $283.7M | $797M | $808.2M | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | $253.5M | -$620.1M | |
| Income Tax Expense | $105.3M | $121.3M | $226M | $195.1M | $270.9M | |
| Net Income to Company | $45.8M | $406M | $890.9M | $914.4M | $1.1B | |
| Minority Interest in Earnings | $5.4M | $2.3M | -$7.3M | -$8.6M | -$9.8M | |
| Net Income to Common Excl Extra Items | -$380.5M | $165.9M | $750M | $858.1M | $182.8M | |
| Basic EPS (Cont. Ops) | -$0.52 | $0.23 | $1.03 | $1.18 | $0.25 | |
| Diluted EPS (Cont. Ops) | -$0.53 | $0.22 | $1.01 | $1.16 | $0.25 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $905M | $1.1B | $1.4B | $1.5B | $1.8B | |
| EBIT | -$111.3M | $418M | $915.7M | $980.3M | $1.3B | |
| Revenue (Reported) | $21.7B | $20.9B | $21.9B | $24.5B | $25.9B | |
| Operating Income (Reported) | $554.3M | $647.4M | $834.8M | $961.3M | $1.1B | |
| Operating Income (Adjusted) | -$111.3M | $418M | $915.7M | $980.3M | $1.3B | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.4B | $4.2B | $3.2B | $2.2B | $2.4B | |
| Short Term Investments | $60.8M | -- | -- | -- | -- | |
| Accounts Receivable, Net | $4.1B | $4.4B | $4.3B | $3.3B | $3.5B | |
| Inventory | $308.7M | $302M | $352.9M | $354.1M | $356.1M | |
| Prepaid Expenses | $241.9M | $228.8M | $251.6M | $243.7M | $213.5M | |
| Other Current Assets | $2.4M | $1.2M | -- | -- | -- | |
| Total Current Assets | $9.1B | $11.4B | $10.2B | $12.4B | $7.1B | |
| Property Plant And Equipment | $2.2B | $1.6B | $1.4B | $1.4B | $1.4B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $6.9B | $6.9B | $6.6B | $6.1B | $6.2B | |
| Other Intangibles | $802.1M | $743.2M | $679.7M | $489.6M | $482.2M | |
| Other Long-Term Assets | $38.1M | $37.7M | $172.4M | $84.2M | $68.6M | |
| Total Assets | $20.7B | $22.4B | $21B | $22.7B | $16.6B | |
| Accounts Payable | $2.3B | $2.6B | $2.7B | $2.7B | $2.9B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $275.3M | $207.6M | $184.4M | $161.7M | $162.6M | |
| Other Current Liabilities | $3.7B | $3.7B | $3.5B | $1.1M | $1.1M | |
| Total Current Liabilities | $9.2B | $10.4B | $9.3B | $10.7B | $6.5B | |
| Long-Term Debt | $5.9B | $6.4B | $5.7B | $5.5B | $4.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $17.4B | $18.7B | $16.5B | $17.7B | $12.4B | |
| Common Stock | $703.2M | $696M | $591.4M | $644.8M | $652.5M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $3.3B | $3.7B | $4.4B | $5B | $4.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $17.9M | $8.3M | $10M | $13.1M | $17.7M | |
| Total Equity | $3.3B | $3.7B | $4.4B | $5B | $4.2B | |
| Total Liabilities and Equity | $20.7B | $22.4B | $21B | $22.7B | $16.6B | |
| Cash and Short Terms | $2.5B | $4.2B | $3.2B | $2.2B | $2.4B | |
| Total Debt | $6B | $7.2B | $5.7B | $6.1B | $5.2B | |
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.4B | $4.2B | $3.2B | $2.2B | $2.4B | |
| Short Term Investments | $60.8M | -- | -- | -- | -- | |
| Accounts Receivable, Net | $4.1B | $4.4B | $4.3B | $3.3B | $3.5B | |
| Inventory | $308.7M | $302M | $352.9M | $354.1M | $356.1M | |
| Prepaid Expenses | $241.9M | $228.8M | $251.6M | $243.7M | $213.5M | |
| Other Current Assets | $2.4M | $1.2M | -- | -- | -- | |
| Total Current Assets | $9.1B | $11.4B | $10.2B | $12.4B | $7.1B | |
| Property Plant And Equipment | $2.2B | $1.6B | $1.4B | $1.4B | $1.4B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $6.9B | $6.9B | $6.6B | $6.1B | $6.2B | |
| Other Intangibles | $802.1M | $743.2M | $679.7M | $489.6M | $482.2M | |
| Other Long-Term Assets | $38.1M | $37.7M | $172.4M | $84.2M | $68.6M | |
| Total Assets | $20.7B | $22.4B | $21B | $22.7B | $16.6B | |
| Accounts Payable | $2.3B | $2.6B | $2.7B | $2.7B | $2.9B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $275.3M | $207.6M | $184.4M | $161.7M | $162.6M | |
| Other Current Liabilities | $3.7B | $3.7B | $3.5B | $1.1M | $1.1M | |
| Total Current Liabilities | $9.2B | $10.4B | $9.3B | $10.7B | $6.5B | |
| Long-Term Debt | $5.9B | $6.4B | $5.7B | $5.5B | $4.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $17.4B | $18.7B | $16.5B | $17.7B | $12.4B | |
| Common Stock | $703.2M | $696M | $591.4M | $644.8M | $652.5M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $17.9M | $8.3M | $10M | $13.1M | $17.7M | |
| Total Equity | $3.3B | $3.7B | $4.4B | $5B | $4.2B | |
| Total Liabilities and Equity | $20.7B | $22.4B | $21B | $22.7B | $16.6B | |
| Cash and Short Terms | $2.5B | $4.2B | $3.2B | $2.2B | $2.4B | |
| Total Debt | $6B | $7.2B | $5.7B | $6.1B | $5.2B | |
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $72.4M | $405.2M | $893.5M | $900M | $1.1B | |
| Depreciation & Amoritzation | $998.2M | $718.3M | $502.9M | $486.7M | $508.2M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $353.2M | -$314.3M | -$517.2M | -$216.8M | -$230.3M | |
| Change in Inventories | $23.4M | -- | -$79.2M | -$11.7M | -$2.2M | |
| Cash From Operations | $704.1M | $1.2B | $1.1B | $1.4B | $1.4B | |
| Capital Expenditures | $443.4M | $353.8M | $292.7M | $359.2M | $387.1M | |
| Cash Acquisitions | -$18.9M | -$87.3M | -$50.6M | -$22.3M | -$99.5M | |
| Cash From Investing | -$479.1M | -$362.1M | -$424.8M | -$513.2M | -$1.1B | |
| Dividends Paid (Ex Special Dividend) | -$473.5M | -- | -$323.5M | -$374M | -$1.5B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.6B | $1.3B | $122.1M | $578M | $420.6M | |
| Long-Term Debt Repaid | -$2.6B | -$6M | -$769.2M | -$584.4M | -$1.3B | |
| Repurchase of Common Stock | -$43.5M | -$13.1M | -$14.3M | -$60.6M | -$56.2M | |
| Other Financing Activities | -$25.6M | -$16.7M | -$23.1M | -$48.9M | $1.2B | |
| Cash From Financing | $220.6M | $943M | -$1.2B | -$686.4M | -$1.5B | |
| Beginning Cash (CF) | $1.9B | $2.4B | $3.9B | $3.4B | $3.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $445.6M | $1.8B | -$506.2M | $216.8M | -$1.2B | |
| Ending Cash (CF) | $2.3B | $4.2B | $3.5B | $3.4B | $2.3B | |
| Levered Free Cash Flow | $260.7M | $819.9M | $846.2M | $1.1B | $1B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | $1.4M | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $45.8M | $406M | $890.9M | $914.4M | $1.1B | |
| Depreciation & Amoritzation | $1B | $721.1M | $497M | $495.6M | $511.3M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $400.5M | -$325M | -$564.5M | -$209.9M | -$231.7M | |
| Change in Inventories | $24.4M | $343.5K | -$76.8M | -$11.8M | -$2.2M | |
| Cash From Operations | $716.2M | $1.2B | $1.1B | $1.5B | $1.4B | |
| Capital Expenditures | $447.2M | $355M | $290M | $365.9M | $389.5M | |
| Cash Acquisitions | -$18.9M | -$87.2M | -$51.6M | -$22.7M | -$100.1M | |
| Cash From Investing | -$480.8M | -$362.5M | -$423.1M | -$522.6M | -$1.1B | |
| Dividends Paid (Ex Special Dividend) | -$469.5M | -- | -$332.9M | -$376.6M | -$1.5B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.7B | $1.3B | $118.7M | $588.7M | $423.2M | |
| Long-Term Debt Repaid | -$2.6B | -$6.1M | -$783.6M | -$595.2M | -$1.3B | |
| Repurchase of Common Stock | -$43.1M | -$13.3M | -$14.7M | -$61M | -$56.6M | |
| Other Financing Activities | -$25.5M | -$16.7M | -- | -$50.2M | $1.2B | |
| Cash From Financing | $228.7M | $932.8M | -$1.2B | -$694.1M | -$1.5B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $366.2M | $1.8B | -$481.3M | $136M | -$1.2B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $268.9M | $821.4M | $801.9M | $1.1B | $1B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | $1.4M | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get SDXAY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SDXAY
Sector
P/E ratio
65.88x
16.83x
PEG ratio
--
0.22x
P/B ratio
2.82x
1.45x
Price / LTM sales
0.46x
0.71x
Growth Metrics
SDXAY
Sector
Revenue growth
--
0.14%
Earnings growth
--
--
Revenue (5-year growth)
0.67%
3.45%
Earnings forecast
--
$0.30
Profitability
SDXAY
Sector
Profitability FY 2024
$3.1B
$503.7M
Return on invested capital
2.93%
5.17%
Return on assets
1.5%
3.13%
Return on equity
6.52%
7.63%
Earnings Date
Last Earnings Date
Oct
24
Next Earnings Date
Apr
18
Estimated Next Earnings Date
Jan
23
Balance Sheet
SDXAY
Sector
Total cash
$1.7B
$157.7M
Short term investments
--
$60.7M
Total assets
$16.6B
$1.7B
Long term debt
$5.2B
$111.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
